BioCentury
ARTICLE | Company News

Ingenium, Oxagen deal

June 9, 2003 7:00 AM UTC

Ingenium will use its INGENOtyping technology to develop animal models with defined gene alterations for metabolic targets supplied by Oxagen. Oxagen will then perform functional studies on the Ingeni...